Elicera Therapeutics AB (ELIC) — Financial Flexibility Index
Elicera Therapeutics AB (ELIC) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of Skr-4.74 Million (operating CF Skr-4.74 Million minus capex Skr0.00) represents -1% of total liabilities (Skr6.97 Million). Check Elicera Therapeutics AB (ELIC) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elicera Therapeutics AB Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Elicera Therapeutics AB across 8 annual periods. See how liquid is Elicera Therapeutics AB's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Elicera Therapeutics AB (2017–2024)
Year-by-year free cash flow to debt coverage for Elicera Therapeutics AB. For the full company profile including market capitalisation, see ELIC market cap.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.45x | Skr-23.46 Million | Skr-23.46 Million | Skr6.79 Million | ▼ -219.0% |
| 2023 | -1.08x | Skr-14.92 Million | Skr-14.92 Million | Skr13.78 Million | ▼ -70.7% |
| 2022 | -0.63x | Skr-8.57 Million | Skr-8.57 Million | Skr13.51 Million | ▲ +88.9% |
| 2021 | -5.72x | Skr-14.29 Million | Skr-14.29 Million | Skr2.50 Million | ▼ -1489.8% |
| 2020 | -0.36x | Skr-846.37K | Skr-905.25K | Skr2.35 Million | ▲ +99.4% |
| 2019 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2018 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2017 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | — |